A panel of experts will discuss Africa’s critical role in the global efforts to develop a vaccine for COVID-19. Topics include the current status and safety of clinical trials of vaccines; how vaccines are developed and distributed; the policy and regulatory requirements for development, registration, access and use of vaccines; the safety and efficacy of vaccines; the role of public sentiment in accepting or rejecting a COVID vaccine; and political will and its impact on vaccine access on the continent.
Additional topics for discussion include other measures for controlling the pandemic on the continent and the potential role of a COVID-19 vaccine in those efforts; the status of Africa’s efforts to move into vaccine development; and Africa’s roles and responsibilities within the context of the global response to COVID.
The expert panelists are: Prof. Shabir A. Madhi, professor of vaccinology at the University of the Witwatersrand, Johannesburg, South Africa; Dr. Michael Owusu, a clinical microbiologist and a lecturer at the Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Ghana; and Prof. Omu Anzala, professor of virology & immunology and lead research scientist at KAVI-Institute of Clinical Research, University of Nairobi, Kenya. Dr. Mercy Korir, a health journalist and editor with The Standard Group in Kenya, will moderate.
It will also be live-streamed on Facebook.